In accordance with Safran et al this study shows no consistent HER2 gene amplification in IHC +3 expressing pancreatic adenocarcinoma as seen in other cancers, suggesting some other pathways resulting in protein overexpression. The gene discussed is ERBB2; the disease is cancer.